On June 1, 2022, Gail Cawkwell, M.D., Ph.D., notified Intercept Pharmaceuticals, Inc. of her decision to resign from her position as the Company's Senior Vice President, Medical Affairs, Safety & Pharmacovigilance, in order to pursue other opportunities. Dr. Cawkwell's resignation was not the result of any disagreement regarding any matter related to the Company's operations, policies or practices.
Intercept Pharmaceuticals, Inc.
Equities
ICPT
US45845P1084
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+7.80% | 111B | |
+11.19% | 106B | |
-12.21% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.77% | 16.81B | |
+38.63% | 12.54B | |
-24.51% | 8.09B |